Basic Information


GTO ID GTC2652
Trial ID NCT04837547
Disease Diffuse Intrinsic Pontine Glioma | Neuroblastoma
TherapymRNA vaccine
Treatment ttRNA-DC
Co-treatment TTRNA-xALT
PhasePhase1
Recruitment statusRecruiting
TitlePEACH TRIAL- Precision mEdicine and Adoptive Cellular tHerapy for the Treatment of Recurrent Neuroblastoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG)
Year2021
CountryUnited States
Company sponsorGiselle Sholler
Other ID(s)BCC017
Vector information
Vectordendritic cell

Clinical Result

Cohort1: Diffuse Intrinsic Pontine Glioma (DIPG)
Administration route None
Dosage DCs: Dose Level 1, 3E7 cells/kg; Dose Level+1: 3E8 cells/kg ; Dose Level-1: 3E6 cells/kg
Age Child, Adult
Cohort2: Relapsed/Refractory Neuroblastoma (NB)
Administration route None
Dosage DCs: Dose Level 1, 3E7 cells/kg; Dose Level+1: 3E8 cells/kg ; Dose Level-1: 3E6 cells/kg
Age Child, Adult

Relationship Graph

Overview of Knowledge Graph